Vimetin Antibody – Mouse Monoclonal

Intended Use: The TIM3 [IHC003] antibody is intended for qualified laboratories to qualitatively identify by light microscopy the presence of associated antigens in sections of formalin-fixed, paraffin-embedded tissue sections using IHC test methods.
Description: T-cell Immunoglobulin and Mucin-Domain-Containing Molecule-3 (TIM3) is present on T-helper type 1 lymphocytes and other immune cells including dendritic cells and natural killer cells. TIM3 is overexpressed in CD4+ tumor-infiltrating lymphocytes, including those with non-small cell lung cancer associated with poor prognoses. TIM3 has recently emerged as a potential target for cancer immunotherapy.

1. Monney L, et al. Nature. 2002; 415:536-41.
2. Sánchez-Fueyo A, et al. Nat Immunol. 2003; 4:1093-101.
3. Anderson AC. Cancer Immun Res. 2014; 2:393-8.
4.Gao X, et al. PLoS One. 2012; 7:e30676.

Small volumes of anti-Vimetin antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

MBS344083 is an antibody targeting Vimetin. Reactive in Human. Host: Mouse.